| It is synthetic cyclic tetradecapeptide with structure of hypothalamic hormone that inhibits release of growth hormone.
| Composition : | 250mcg | | Indications : | Acute bleeding oesophageal varices, upper GI bleeding from haemorrhagic gastritis or gastric/duodenal ulcer, intestinal and pancreatic fistulae. Hypersecretory tumours of intestinal tract. | | Contraindications : | Hypersensitivity. | | Safety Profile : | Monitor blood glucose levels. | | Adverse Effects : | Flushing, nausea, bradycardia, dyspepsia, steatorrhoea, hypochlorhydria, diarrhoea. | | Dosage : | Bleeding oesophageal varices i.v. bolus of 250mcg followed by 6mg/day. Continuous infusion for 5 days. Upper GI bleeding 250mcg IV bolus followed by 3mg/12 hrly for 2-3 days. Intestinal and pancreatic fistulae 6mg/day i.v. for 14 days. | | Purity : | Not less than 99%. | |  |